Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial

By  

Cerebrovascular Diseases, Vol. 32, Iss. 1, 2011-05 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-04 ,pp. : 509-518

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Deep Vein Thrombosis Prophylaxis in Internal Medicine Patients

By Wade W.E.   Chisholm M.A.  

Thrombosis Research, Vol. 94, Iss. 1, 1999-04 ,pp. : 65-68

Elsevier

Access to resources Recommend Favorite

Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial

By  

Cerebrovascular Diseases, Vol. 29, Iss. 3, 2010-01 ,pp. : 275-281

Karger

Access to resources Recommend Favorite

Subcutaneous Histamine versus Topiramate in Migraine Prophylaxis: A Double-Blind Study

By  

European Neurology, Vol. 59, Iss. 5, 2008-02 ,pp. : 237-242

Karger

Access to resources Recommend Favorite